The story of Viagra presents a intricate picture for shareholders. While the initial introduction generated substantial profits, the expiration of its intellectual property protection opened the floodgates to cheaper https://hyperbookmarks.com/story21623238/the-copyright-and-the-pharmaceutical-industry-a-precarious-opportunity